Thus, in both Groups I and II, sFasL concentration is within normal range which has been corroborated in several other studies.[ 1 , 2 ] But in contrary to most of the studies who reported normal sFasL levels in DPN,[ 1 , 2 ] we found highly significant decrease in sFasL level in patients with DPN, the mean being 87.53 ± 3.49 and intergroup statistical significance being <0.0001 when compared with both healthy and diabetic controls.
← all excerpts
Evaluation of diabetic polyneuropathy in Type 2 diabetes mellitus by nerve conduction study and association of severity of neuropathy with serum sFasL level.
1
—
—